Takeda Pharmaceuticals U.S.A., Inc.

Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is committed to strive toward better health for patients through leading innovation in medicine. It is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Japan's largest pharmaceutical company and one with a 230-year heritage.  TPUSA currently markets metabolic, gout, gastrointestinal, renal, and central nervous system treatments. Takeda's U.S. clinical development activities are conducted via Takeda Global Research & Development Center, Inc. (TGRD).